Educational Intervention for Ovarian Cancer

City of Hope Medical Center, Duarte, CA
Ovarian Cancer+6 More ConditionsEducational Intervention - Other
All Sexes
What conditions do you have?

Study Summary

This trial studies a web-based cancer education tool called HOPE-Genomics. The tool provides patients with information about genomic testing and their own genomic test results. The goal is to improve patient's genomic knowledge and quality of patient-centered care.

Eligible Conditions
  • Ovarian Cancer
  • Breast Cancer
  • Prostate Cancer
  • Pancreatic Cancer
  • Cancer
  • Lung Cancer
  • Colorectal Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Up to 12-month period after results disclosure

Up to 12-month period after results disclosure
Operationalization of contextual guideline concordant care
Up to 9 months
General genomic knowledge
Genetically-guided care
HOPE-Genomics tool usage
Recall rates of personal genomic results
Test-related distress

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

3 Treatment Groups

Arm I (usual care)
1 of 3
Arm II (genomics test results, HOPE-Genomics)
1 of 3
Arm III (HOPE-Genomics, genomics test results)
1 of 3

Active Control

Experimental Treatment

435 Total Participants · 3 Treatment Groups

Primary Treatment: Educational Intervention · No Placebo Group · N/A

Arm II (genomics test results, HOPE-Genomics)Experimental Group · 3 Interventions: Educational Intervention, Survey Administration, Genomic Profile · Intervention Types: Other, Other, Procedure
Arm III (HOPE-Genomics, genomics test results)Experimental Group · 2 Interventions: Educational Intervention, Survey Administration · Intervention Types: Other, Other
Arm I (usual care)ActiveComparator Group · 2 Interventions: Best Practice, Survey Administration · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 12-month period after results disclosure

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
535 Previous Clinical Trials
2,249,567 Total Patients Enrolled
7 Trials studying Ovarian Cancer
217 Patients Enrolled for Ovarian Cancer
National Cancer Institute (NCI)NIH
13,272 Previous Clinical Trials
41,230,293 Total Patients Enrolled
286 Trials studying Ovarian Cancer
73,866 Patients Enrolled for Ovarian Cancer
Stacy W GrayPrincipal InvestigatorCity of Hope Comprehensive Cancer Center
1 Previous Clinical Trials
240 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been diagnosed with lung, breast, colorectal, pancreatic, ovarian or prostate cancer.

Frequently Asked Questions

How many participants are currently engaged in this research?

"Affirmative, the information posted on shows that this experiment is actively enrolling participants as of now. It was first uploaded December 30th 2021 and last revised February 11th 2022 to seek 435 subjects from 1 site." - Anonymous Online Contributor

Unverified Answer

Are there any available openings for participation in this trial?

"Affirmative, the information provided on denotes that this trial is actively enlisting patients as of now. The study was first published on December 30th 2021 and updated recently on February 11th 2022, with a target enrollment goal of 435 subjects from 1 site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.